Overactive Bladder - Results from #2160

Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey - Abstract July 2, 2012

FDA approves overactive bladder treatment Myrbetriq™ (mirabegron) from Astellas June 29, 2012

Full prescribing information for MYRBETRIQ™ (mirabegron) extended-release tablets, for oral use, indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency June 29, 2012

FDA approves Myrbetriq for overactive bladder June 29, 2012

Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB) - Abstract June 29, 2012

Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention - Abstract June 28, 2012

Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score - Abstract June 27, 2012

Differences in transverse and longitudinal rat detrusor contractility under K+ channel blockade - Abstract June 27, 2012

Overactive bladder after transurethral resection of prostate treated with electroacupuncture therapy and tolterodine - Abstract June 26, 2012

Phase IIb, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine effects of elocalcitol in women with overactive bladder and idiopathic detrusor overactivity - Abstract June 25, 2012

Risk factors for new-onset overactive bladder in older subjects: Results of the Fujiwara-Kyo study - Abstract June 22, 2012

Botox(®) for idiopathic overactive bladder: Efficacy, duration and safety. Effectiveness of subsequent injection - Abstract June 21, 2012

Transcutaneous electrical nerve stimulation: An effective treatment for refractory non-neurogenic overactive bladder syndrome? - Abstract June 20, 2012

High frequency of overlap between functional dyspepsia and overactive bladder - Abstract June 19, 2012

Concepts in the management of the overactive bladder in women - Abstract June 18, 2012

Post-vasectomy pain syndrome: Clinical features and treatment options - Abstract June 15, 2012

Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder - Abstract June 13, 2012

Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity - Abstract June 13, 2012

Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis - Abstract June 11, 2012

Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: Insights into factors associated with dose escalation - Abstract June 8, 2012

Page 109 of 122